| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Jun'11 | Jun'10 | Jun'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||
Net income | ||||||||||
38,793 | 37,284 | 41,823 | 31,184 | 26,191 | 23,675 | -4,929 | 1,624 | -1,313 | 8,738 | -69,123 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | ||||||||||
11,572 | 11,362 | 11,308 | 11,253 | 12,382 | 12,325 | 12,009 | 11,568 | 8,843 | 8,631 | 11,946 |
Gain on sale of equity method investment | ||||||||||
0 | 0 | 11,381 | 0 | 0 | - | - | - | - | - | - |
Gain on sale of bioplastics manufacturing business | ||||||||||
- | - | - | - | - | - | 1,453 | 0 | - | - | - |
Gain on property insurance recoveries | ||||||||||
- | - | - | 230 | 0 | 8,290 | 0 | 4,055 | - | - | - |
Gain on sale of assets | ||||||||||
- | - | - | 872 | 0 | -38 | -47 | 832 | -322 | 1,731 | 285 |
Share-based compensation | ||||||||||
3,304 | 3,099 | 2,574 | 2,402 | 1,414 | 930 | 932 | 969 | 1,164 | 491 | 14 |
Loss on joint venture formation | ||||||||||
- | - | - | - | - | - | - | - | - | 2,294 | - |
Loss on impairment of assets | ||||||||||
- | - | - | - | - | - | - | - | - | - | 10,282 |
Deferred income taxes, including change in valuation allowance | ||||||||||
-252 | -1,665 | 3,420 | -681 | -1,349 | -1,570 | 152 | - | - | - | -7,217 |
Changes in operating assets and liabilities: | ||||||||||
Equity method investment loss | ||||||||||
0 | 0 | -348 | 4,036 | 6,102 | -10,137 | 204 | 301 | 1,540 | 2,173 | 114 |
Distributions received from equity method investee | ||||||||||
0 | 0 | 7,131 | 3,300 | 0 | 4,835 | 0 | - | - | - | - |
Excess tax benefits | ||||||||||
- | - | - | - | - | -463 | 0 | - | - | - | - |
Other, net | ||||||||||
116 | 0 | -61 | 0 | -453 | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Receivables, net | ||||||||||
2,134 | 4,450 | 8,262 | -4,585 | -2,002 | 4,851 | -7,511 | 7,521 | 10,170 | -729 | -15,684 |
Restricted cash | ||||||||||
- | - | - | - | - | - | -12 | -7,593 | 57 | 768 | 200 |
Inventory | ||||||||||
28,162 | 15,620 | 14,291 | 20,106 | 24,260 | -476 | -1,542 | 5,450 | 2,568 | -3,184 | -40,703 |
Prepaid expenses | ||||||||||
728 | -862 | 498 | 622 | -117 | 331 | 129 | -261 | -316 | 537 | 1,130 |
Income taxes payable (refundable) | ||||||||||
275 | -1,268 | -725 | 3,390 | -1,073 | -78 | 224 | -324 | 53 | -5,467 | -2,525 |
Accounts payable | ||||||||||
2,107 | -2,542 | 9,540 | -3,178 | 3,653 | -5,928 | 2,571 | -4,302 | 5,907 | 1,439 | -3,063 |
Accounts payable to affiliate, net | ||||||||||
0 | 0 | -3,349 | 1,058 | -1,042 | 2,129 | -2,804 | -2,159 | 1,215 | 4,951 | - |
Accrued expenses | ||||||||||
-4,547 | 551 | 2,278 | -1,407 | 2,351 | -373 | 3,264 | 593 | -3,111 | 1,871 | -694 |
Deferred credits | ||||||||||
-332 | -586 | -827 | -424 | -697 | 174 | -208 | -630 | -881 | -811 | -846 |
Other, net | ||||||||||
12 | -588 | 289 | 477 | 703 | 699 | 876 | 1,081 | 659 | 3,277 | -4,968 |
Change in derivatives | ||||||||||
- | - | - | - | - | - | - | 2,034 | -2,267 | 418 | -1,753 |
Gains previously deferred in other comprehensive income | ||||||||||
- | - | - | - | - | - | - | - | - | - | 2,149 |
Other, net | ||||||||||
- | - | - | - | -481 | 272 | 17 | 195 | -271 | -241 | 124 |
Net cash provided by (used in) operating activities | ||||||||||
19,722 | 33,481 | 33,471 | 19,721 | 18,662 | 15,812 | 17,300 | -5,026 | 3,139 | 32,667 | 3,158 |
Cash Flows from Investing Activities | ||||||||||
Cash Flows from Investing Activities | ||||||||||
Additions to property, plant, and equipment | ||||||||||
16,730 | 31,046 | 21,055 | 17,922 | 30,526 | 6,953 | 6,208 | 9,229 | 12,775 | 2,062 | 2,069 |
Acquisition of business | ||||||||||
- | - | - | 1,551 | 0 | 0 | - | - | - | - | - |
Investments in/ advances to equity method investments | ||||||||||
- | - | - | - | - | - | - | 500 | - | - | - |
Divestiture of equity method investment, net | ||||||||||
0 | 0 | 22,832 | 351 | 0 | 0 | 2,797 | 0 | - | - | - |
Deferred compensation plan investments | ||||||||||
1,201 | 0 | 0 | - | - | - | - | - | - | - | - |
Proceeds from property insurance recoveries | ||||||||||
- | - | - | 230 | 0 | 8,450 | 0 | -9,103 | - | - | - |
Investments in/ advances to joint ventures | ||||||||||
- | - | - | - | - | - | - | - | - | 1,213 | - |
Proceeds from sale of interest in joint venture, net | ||||||||||
- | - | - | - | - | - | - | - | - | 13,951 | - |
Proceeds from sale of property | ||||||||||
- | - | - | 1,209 | 0 | 5 | 0 | 3,263 | - | 5,367 | 744 |
Other, net | ||||||||||
- | - | - | - | - | - | - | -568 | - | - | - |
Net cash used in investing activities | ||||||||||
-17,931 | -31,046 | 1,777 | -17,683 | -30,526 | 1,502 | -3,411 | 3,205 | -12,775 | 16,043 | -1,325 |
Cash Flows from Financing Activities | ||||||||||
Cash Flows from Financing Activities | ||||||||||
Payment of dividends and dividend equivalents | ||||||||||
6,856 | 5,500 | 17,380 | 2,066 | 1,087 | 907 | 916 | 914 | 891 | - | - |
Purchase of treasury stock | ||||||||||
- | - | - | - | - | - | - | - | - | - | 40 |
Purchase of treasury stock for tax withholding on equity-based compensation | ||||||||||
5,489 | 2,324 | 4,663 | 1,518 | 15,408 | 672 | 540 | 84 | 33 | 26 | 34 |
Proceeds from stock plans | ||||||||||
- | - | - | - | - | - | - | - | 48 | - | 12 |
Exercise of stock options | ||||||||||
- | - | - | - | - | - | - | - | -452 | 221 | - |
Loan fees paid related to borrowings | ||||||||||
0 | 0 | 377 | 114 | 348 | 66 | 0 | 644 | - | 229 | - |
Proceeds from long-term debt | ||||||||||
20,000 | 0 | 20,000 | 0 | 2,700 | 0 | 0 | - | 7,335 | 2,032 | 7,350 |
Principal payments on long-term debt | ||||||||||
386 | 372 | 358 | 2,346 | 1,641 | 1,555 | 1,683 | 1,671 | 699 | 26,379 | 3,776 |
Proceeds from credit agreement - revolver | ||||||||||
17,440 | 28,966 | 25,930 | 27,184 | 26,092 | 62,146 | 95,512 | 127,089 | 317,179 | 214,305 | 156,980 |
Payments on credit agreement - revolver | ||||||||||
28,140 | 21,264 | 56,885 | 22,356 | 3,338 | 73,476 | 103,405 | 122,338 | 312,521 | 232,443 | 162,147 |
Other, net | ||||||||||
-76 | 0 | 0 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||||
-3,507 | -494 | -33,733 | -1,216 | 6,970 | -14,530 | -11,032 | 1,438 | 10,870 | -42,519 | -1,655 |
Increase (decrease) in cash and cash equivalents | ||||||||||
-1,716 | 1,941 | 1,515 | 822 | -4,894 | 2,784 | 2,857 | -383 | 1,234 | 6,191 | 178 |